FORMULATION INCLUDING ANTI-VEGFR2 ANTIBODY

The present invention relates to a formulation including an anti-VEGFR2 antibody. Specifically, the present invention relates to an anti-VEGFR2 antibody, a formulation including the anti-VEGFR2 antibody and a use thereof, in particular a pharmaceutical formulation including the anti-VEGFR2 antibody,...

Full description

Saved in:
Bibliographic Details
Main Authors HU, Yudi, GUO, Huanhuan, LI, Hongjun, SHAO, Qi, QIAN, Xueming, ZHANG, Fan
Format Patent
LanguageChinese
English
French
Published 18.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a formulation including an anti-VEGFR2 antibody. Specifically, the present invention relates to an anti-VEGFR2 antibody, a formulation including the anti-VEGFR2 antibody and a use thereof, in particular a pharmaceutical formulation including the anti-VEGFR2 antibody, a buffering agent, a stabilizer and a surfactant. In addition, the present invention relates to a use of the formulation or the antibody in the prevention or treatment of diseases. La présente invention concerne une formulation comprenant un anticorps anti-VEGFR2. Spécifiquement, la présente invention concerne un anticorps anti-VEGFR2, une formulation comprenant l'anticorps anti-VEGFR2 et son utilisation, en particulier une formulation pharmaceutique comprenant l'anticorps anti-VEGFR2, un agent tampon, un stabilisant et un tensioactif. De plus, la présente invention concerne une utilisation de la formulation ou de l'anticorps dans la prévention ou le traitement de maladies. 本发明涉及包含抗VEGFR2抗体的制剂。具体而言,本发明涉及抗VEGFR2抗体、
Bibliography:Application Number: WO2023CN123939